beta-interferon


Also found in: Dictionary, Thesaurus, Acronyms, Wikipedia.
Related to beta-interferon: Interferon beta-1a

beta-interferon

n.
A family of glycoproteins that are produced by fibroblasts, have antiviral properties, and are used in the treatment of multiple sclerosis.
References in periodicals archive ?
The guidelines for beta-interferon treatment for relapsing-remitting MS state that a person must be over 18, mobile and not pregnant.
A spokesman for the Department of Health said: 'It is because of the variations in prescribing beta-interferon that the government referred it to NICE.
Those with very low detectable blood levels of IL-17F responded well to beta-interferon treatment, experiencing no relapses or instances of required steroids (to quickly shut down a malfunctioning immune system).
The other side of the coin is that beta-interferon, if it's given only to those who are predisposed to respond to it, could turn out to be a far better drug than we ever imagined.
Actual results may differ materially from these projections depending on Genzyme Transgenics' ability to obtain patents for transgenic hGH and transgenic beta-interferon, the company's ability to transfer the production of the proteins from mice to dairy animals, the outcome of clinical trials, and the timing and content of decisions made by the U.
The addition of heparin and beta-interferon will address the need for an easily administered antithrombiotic medication as well as extend central nervous system applications.
The application of Aegis' non-invasive drug delivery technology to a new intranasal heparin and beta-interferon provides ITI a unique benefit as it develops exciting new therapeutic products that hold advantages for both patients and healthcare professionals.
Furthermore, Copaxone(R) is the only drug available for patients who do not benefit from or cannot tolerate beta-interferon.
4 billion global market in 1999, based on publicly reported sales data for its beta-interferon product, Rebif(r) (US$143 million), and three competing products.
As a widely accepted first-line therapy and the drug of choice for patients who do not benefit or cannot tolerate beta-interferon, Copaxone(R) is poised to gain its share rapidly.
Flippin served as co-chair of the Southern California Regional Beta-Interferon Advisory Panel from 1993 to 1999, and was a member of the Kaiser Permanente Southern California Regional Pallidotomy Review Panel from 1997 to 1999.

Full browser ?